文献速递静脉血栓栓塞

COVID-19患者静脉血栓栓塞与炎症及凝血标志物的回顾性队列研究

Venous thrombosis, thromboembolism, biomarkers of inflammation, and coagulation in coronavirus disease 2019.
PubMed 文献 · J Vasc Surg Venous Lymphat Disord · 2020-11-12

该回顾性队列研究纳入2020年3月13日至5月18日因COVID-19住院并因疑似VTE接受超声检查的138例患者,其中44例(31.9%)存在VTE证据。单变量分析显示入院CRP、血小板计数升高及男性与VTE相关,但多变量分析仅男性保持显著。年龄、活动性恶性肿瘤、DIC及入院D-二聚体升高为死亡独立预测因素。

要点

  • COVID-19住院患者疑似VTE者中VTE发生率为31.9%。
  • 多变量分析仅男性与VTE独立相关(OR 2.37)。
  • 高龄、活动性恶性肿瘤、DIC和入院D-二聚体升高独立预测死亡。

核心结论

  • COVID-19住院患者中男性与VTE独立相关,而CRP和血小板计数仅在单变量分析中与VTE相关。
  • 高龄、活动性恶性肿瘤、DIC和入院D-二聚体升高为死亡的独立预测因素。

研究设计与样本

  • 回顾性观察性队列研究,纳入2020年3月13日至5月18日因COVID-19住院且因疑似VTE接受超声影像检查的患者138例。
  • 收集入院时及超声检查前后最多七个时间点的D-二聚体、纤维蛋白原、凝血酶原时间、部分凝血活酶时间、血小板计数、CRP和高敏肌钙蛋白T数据。
  • 采用混合效应logistic回归、线性回归和Cox比例风险模型评估实验室标志物与VTE及院内结局的关系。

主要发现

  • 138例接受影像学检查的患者中,44例(31.9%)存在VTE证据。

临床怎么用

  • 对COVID-19住院患者应关注男性、入院CRP及血小板计数升高者,警惕VTE可能。
  • 入院D-二聚体升高、高龄、活动性恶性肿瘤或DIC提示死亡风险增高,需加强监测。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: Coronavirus disease 2019 (COVID-19) is associated with abnormal inflammatory and coagulation markers, potentially mediating thrombotic events. Our objective was to investigate the incidence, time course, laboratory features, and in-hospital outcomes of COVID-19 patients with suspected venous thromboembolism (VTE). METHODS: A retrospective observational cohort study was conducted of patients hospitalized with COVID-19 who had undergone ultrasound imaging for suspected VTE from March 13 to May 18, 2020. The medical records of the included patients were reviewed for D-dimer, fibrinogen, prothrombin time, partial thromboplastin time, platelet count, C-reactive protein (CRP), and high-sensitivity troponin T at admission and at up to seven time points before and after ultrasound examination. The clinical outcomes included superficial venous thrombosis, deep vein thrombosis, pulmonary embolism, intubation, and death. Mixed effects logistic, linear, and Cox proportional hazards methods were used to evaluate the relationships between the laboratory markers and VTE and other in-hospital outcomes. RESULTS: Of 138 patients who had undergone imaging studies, 44 (31.9%) had evidence of VTE. On univariable analysis, an elevated admission CRP (odds ratio [OR], 1.05; 95% confidence interval [CI], 1.01-1.09; P = .02; per 10-U increase in CRP), platelet count (OR, 1.48; 95% CI, 1.04-2.12; P = .03; per 1000-U increase in platelet count), and male sex (OR, 2.64; 95% CI, 1.19-5.84; P = .02), were associated with VTE. However only male sex remained significant on multivariable analysis (OR, 2.37; 95% CI, 1.01-5.56; P = .048). The independent predictors of death included older age (hazard ratio [HR], 1.04; 95% CI, 1.00-1.07; P = .04), active malignancy (HR, 4.39; 95% CI, 1.39-13.91; P = .01), elevated admission D-dimer (HR, 1.016; 95% CI, 1.003-1.029; P = .02), and evidence of disseminated intravascular coagulation (HR, 4.81; 95% CI, 1.76-13.10; P = .002). CONCLUSIONS: Male sex, elevated CRP, and elevated platelet count at admission were associated with VTE on univariable analysis. However, only male sex remained significant on multivariable analysis. Older age, active malignancy, disseminated intravascular coagulation, and elevated D-dimer at admission were independently associated with death for patients hospitalized with COVID-19.

来源:J Vasc Surg Venous Lymphat Disord,查看原文。版权归原作者所有。

引用

  1. Thondapu V, Montes D, Rosovsky R, et al. Venous thrombosis, thromboembolism, biomarkers of inflammation, and coagulation in coronavirus disease 2019. J Vasc Surg Venous Lymphat Disord. 2020. PMID: 33188961. doi:10.1016/j.jvsv.2020.11.006

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。